Business Practice

How is the business of making medicine changing in light of the COVID-19 pandemic?

When developing countermeasures against COVID-19, resource-poor settings should not be forgotten.

What measures can companies take to ensure the safety of their employees amid the COVID-19 outbreak?

Robert Dudley reveals his lessons learned and shares how he has tackled the challenges of launching the first oral TRT softgel approved by the FDA.

What’s new in business?

Under pressure to deliver results, how can the pharmaceutical industry handle the current COVID-19 crisis to help patients around the world?

An online platform could help create a more diverse workforce.

As the industry's reliance on CDMOs increases, how can the sector adapt to meet companies' needs?

Sitting Down With… Mike McMullen, President and CEO, Agilent Technologies, Santa Clara, California, USA.

Digital technologies are here – but are they being used adequately?